Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate Cancer

NCT00659438 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: ZD6474 (Vandetanib)
DRUG: Bicalutamide
DRUG: Placebo

Sponsor

Genzyme, a Sanofi Company